Clinical Trial Update: A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Vonicog alfa (recombinant von Willebrand factor) in children with severe von Willebrand disease is currently recruiting, spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• Vonicog alfa (vonicog alfa)

Snippet

Sponsor: Takeda | Conditions: Von Willebrand Disease (VWD) | Phase 3 | Status: RECRUITING